Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 19,867 shares at $80.40 ($1.6M) on 2024-01-16, disclosed to the SEC on 2024-01-18.
Scheduled sale ($1.6M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.40 | 9,867 | $793K | 49.7% |
| 2 | $80.40 | 9,867 | $793K | 49.7% |
| 3 | $81.06 | 133 | $11K | 0.7% |
| Total | $80.40 avg | 19,867 | $1.6M | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |